MedTrace Logo

Spectroscopic and Colorimetric Analysis of Acanthosis Nigricans in Patients With Hyperinsulinemia

NCT01125150 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9

Last updated 2012-09-06

No results posted yet for this study

Summary

Acanthosis Nigricans is skin disease that associated with hyperinsulinemia. Clinical is velvety hyperpigmented plaques on neck, axilla, groin. If hyperinsulinemia is improved by treated with oral metformin and/ or diet control, acanthosis nigricans would be improved as well. Hyperpigmented plaques will be changed. We assess objective measurement by using spectroscopic and colorimetric analysis.

Conditions

  • Acanthosis Nigricans
  • Hyperinsulinemia
  • Spectroscopic Analysis

Interventions

DRUG

Metformin

Dosage to be determined by Endocrinologist

BEHAVIORAL

Dietary Modification

To be determined by Endocrinologist

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Iltefat Hamzavi, M.D. · Department of Dermatology, Henry Ford Hospital

Eligibility

Min Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01125150 on ClinicalTrials.gov